UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
Conditions: Acute Leukemia; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia/Lymphoma; Burkitt's Lymphoma; Natural Killer Cell Malignancies; Chronic Myelogenous Leukemia; Myelodysplastic Syndrome; Large-cell Lymphoma; Hodgkin Lymphoma; Multiple Myeloma; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Marginal Zone B-cell Lymphoma; Follicular Lymphoma; Lymphoplasmacytic Lymphoma; Mantle-cell Lymphoma; Prolymphocytic Leukemia; Bone Marrow Failure Syndromes; Myeloproliferative Syndromes
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MMF; Drug: Sirolimus; Radiation: TBI; Biological: Umbilical cord blood cell infusion; Biological: ATG
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified December 2016
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MMF; Drug: Sirolimus; Radiation: TBI; Biological: Umbilical cord blood cell infusion; Biological: ATG
Sponsor: Masonic Cancer Center, University of Minnesota
Not yet recruiting - verified December 2016
News Type: